Gsk annual r&d spending
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Gsk R&D Spending Growth & History (GSK)
Gsk's r&d spending was £7.53B for fiscal 2025.
View full Gsk company overviewGsk annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £7.53B | £1.12B | +17.56% |
| 2024 | 2024-12-31 | £6.40B | £178.0M | +2.86% |
| 2023 | 2023-12-31 | £6.22B | £735.0M | +13.39% |
| 2022 | 2022-12-31 | £5.49B | £469.0M | +9.34% |
| 2021 | 2021-12-31 | £5.02B | £226.0M | +4.72% |
| 2020 | 2020-12-31 | £4.79B | £225.0M | +4.93% |
| 2019 | 2019-12-31 | £4.57B | £675.0M | +17.34% |
| 2018 | 2018-12-31 | £3.89B | −£583.0M | −13.03% |
| 2017 | 2017-12-31 | £4.48B | £848.0M | +23.37% |
| 2016 | 2016-12-31 | £3.63B | £68.0M | +1.91% |
| 2015 | 2015-12-31 | £3.56B | — | — |
Gsk quarterly r&d spending
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | £3.47B | £1.44B | +71.25% |
| Q1 2026 | 2026-03-31 | £1.69B | — | — |
| Q4 2025 | 2025-12-31 | £2.35B | — | — |
| Q3 2025 | 2025-09-30 | £1.69B | — | — |
| Q2 2025 | 2025-06-30 | £2.02B | — | — |
Gsk r&d spending trends
Over the last five fiscal years, Gsk's r&d spending increased from £4.79B to £7.53B, a change of £2.73B. The latest reported quarter, Q2 2026, shows £3.47B.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gsk source filings ↗